Common Names: safflower
Safflower has been used in traditional medicine for metabolic disorders. It has anti-hypercholesterolemic and antioxidant effects, but its protective effects against Metabolic Syndrome need further research.
Study explores how safflower treats pulmonary arterial hypertension. Fill gaps in knowledge on mechanisms behind safflower's effectiveness. Relevant for developing treatments for PAH.
Researchers reviewed studies of traditional herbal medicines on heart failure with reduced ejection fraction in rodent models. Common herbs showed positive effects on heart function, but more research is needed to understand timing of treatment for optimal results.
AC combo is effective in treating brain injury. Studying brain metabolism is key to understanding injury mechanisms and AC benefits. More research needed for in-depth understanding.
Scientists found seven metabolites in L. flowers with potential benefits for Alzheimer's disease and hyperglycemia. Compounds showed promising inhibitory effects on key enzymes and antioxidant activity. Worth exploring for potential therapeutic applications.
HSYA and Quer from a plant protect the blood-brain barrier in stroke, improving outcomes and reducing neural damage. They target specific proteins for potential treatment benefits.
Researchers compared CHM bath therapy to topical calcipotriol for psoriasis vulgaris. CHM may be as effective as calcipotriol with added benefits from herb combinations. Consider CHM as an alternative treatment for psoriasis.
Co-treatment with L. and aerial part of shows neuroprotective effects, increasing cell viability, inhibiting ROS production, downregulating BACE and APP, and decreasing Bax expression, suggesting potential for Alzheimer's disease prevention.
HSYA from Carthamus tinctorius protects against cerebral ischemia-reperfusion injury by reducing protein carbonylation, improving neurological function, and enhancing antioxidant capacity through ONOO- scavenging and suppressing protein oxidation.
Combining natural compounds in Chinese medicine, hydroxysafflor yellow A (HSYA) and tenuigenin (TEN), shows promise in treating ischemic stroke by improving various aspects of brain function and suppressing cell apoptosis. This combination modulates signaling pathways, leading to synergistic effects against stroke.
Researchers studied the antihypertensive effects of a Chinese medicine, Danhong Formula (DHF), to understand how it improves endothelial dysfunction and reduces high blood pressure, benefiting cardiovascular health.
DHHP, a Chinese herb pair, relieves myocardial ischemia in rats by regulating gut microbiota. It improves diversity and increases beneficial bacteria while reducing harmful bacteria, offering potential for MI treatment.
This study investigates the molecular regulation and therapeutic effectiveness of the Danshen-Honghua herb pair for cerebral ischemia (CI). By identifying common targets and pathways, it suggests that DH may activate the TNF-α/JNK signaling pathway for CI treatment.
The combination of CTS and TC herbal medicines effectively protected SH-SY5Y cells from oxidative stress, increasing cell survival and reducing LDH release and apoptosis. The combination also inhibited NO and ROS generation and up-regulated antioxidant enzymes and Bcl-2 protein expression while down-regulating Bax expression. This suggests that using CTS and TC together could be beneficial for preventing and treating neurodegenerative diseases caused by oxidative stress.
Scientists have developed two new nanoagents derived from herbal medicine that have shown promising results in treating rheumatoid arthritis by improving joint lubrication and reducing inflammation.
Hydroxysafflor yellow A (HSYA) in safflower may treat traumatic brain injuries, a critical condition with limited treatment options, leading to potential new therapies.
This study explores how Huang Qi and Hong Hua, Chinese herbal remedies for coronary heart disease, work together and their potential benefits.
Researchers conducted a systematic review of scientific articles published between 2010 and 2020 that evaluated the anxiolytic, sedative, and/or hypnotic effects of flower extracts in pre-clinical animal models. They found that some flower extracts have an anxiolytic effect comparable to diazepam, but their therapeutic utility in anxiety disorders needs more investigation. The study compiled the characteristics of anxiety studies in animal models, evaluated locomotor activity, and the hypnotic effect of the extracts. The study revealed that matricaria chamomilla had a sedative effect, and 23 other flower plants had anxiolytic effects. However, more reliable behavioral tests and better experimental designs are needed to obtain more conclusive evidence with clinical significance.
Hydroxysafflor yellow A (HSYA) is a compound found in Carthamus tinctorius L. that has been shown to protect against neurological diseases, including traumatic brain injury (TBI). The methods and mechanisms behind HSYA's neuroprotective effects are not entirely understood.
Radix astragali-safflower (AS) has been used for centuries in China to treat patients with ischemic stroke (IS). In this study, network pharmacology was used to uncover the mechanism of AS in treating IS. AS was shown to promote angiogenesis, which was associated with PTGS2 silence. Middle cerebral artery occlusion/reperfusion (MCAO/R) model rats were then treated with AS and showed improved cerebral infarct volume, neurological and histopathological damage, inhibition of cell apoptosis, and increased levels of PDGF-BB, EPO, and TGF-β1. AS was found to promote angiogenesis in MCAO/R rats by reversing the down-regulation of VEGF and promoting the expression of CD31. The protective mechanism of AS for IS involves PTGS2 silence.
Alzheimer's disease (AD) is a neurodegenerative disease with complicated pathogenic processes including abnormal protein accumulation, oxidative stress, and inflammation. Cholinesterase inhibitors can somewhat alleviate AD symptoms, but new treatment options are needed.
This review article discusses the potential of medicinal plants in treating Parkinson's disease (PD). PD is a neurological disorder that causes motor disorders such as tremors and stiffness. The article includes 12 plant-derived active ingredients and 18 herbal extracts that have been studied for their effects on PD. These compounds have been found to affect PD by targeting pathways associated with the pathogenesis of the disease. Some herbal extracts and active ingredients have shown positive effects in animal models of PD, but additional studies are needed to investigate potential active ingredients and mechanisms of action. This field offers numerous perspectives for future studies on plants and their bioactive compounds.